Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
| 244 | 3 | IMMUNOLOGY//PHAGE DISPLAY//BIOSIMILAR | 47231 |
| 448 | 2 | IMMUNOLOGY//SOMATIC HYPERMUTATION//VDJ RECOMBINATION | 16386 |
| 1263 | 2 | PHAGE DISPLAY//CATALYTIC ANTIBODIES//BISPECIFIC ANTIBODY | 9152 |
| 1376 | 2 | BIOSIMILAR//FCRN//ANTIBODY DRUG CONJUGATE | 8436 |
| 2868 | 2 | FC RECEPTOR//FC GAMMA RECEPTORS//TUFTSIN | 3139 |
| 3238 | 2 | EPCAM//TROP2//EP CAM | 2121 |
| 3258 | 2 | ARTIFICIAL IMMUNE SYSTEM//CONCEPTUAL IMMUNOL GRP//NEGATIVE SELECTION ALGORITHM | 2071 |
| 3285 | 2 | SECRETORY COMPONENT//POLYMERIC IMMUNOGLOBULIN RECEPTOR//IGA1 PROTEASE | 2013 |
| 3397 | 2 | HUMAN HUMAN HYBRIDOMA//IMMUNOGLOBULIN PRODUCTION STIMULATING FACTOR//IN VITRO IMMUNIZATION | 1727 |
| 3768 | 2 | ANTISTREPTOKINASE ANTIBODY//B CELL EPITOPE PREDICTION//PREDETERMINED SPECIFICITY | 1095 |
| 3774 | 2 | IGY//EGG YOLK ANTIBODIES//IMMUNOGLOBULIN Y | 1091 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | IMMUNOLOGY | WoSSC | 314323 | 39% | 3% | 18501 |
| 2 | PHAGE DISPLAY | authKW | 301510 | 2% | 41% | 1118 |
| 3 | BIOSIMILAR | authKW | 156226 | 1% | 64% | 370 |
| 4 | CATALYTIC ANTIBODIES | authKW | 152142 | 1% | 79% | 291 |
| 5 | MABS | journal | 150242 | 1% | 53% | 424 |
| 6 | MOLECULAR IMMUNOLOGY | journal | 145333 | 3% | 18% | 1257 |
| 7 | JOURNAL OF IMMUNOLOGY | journal | 138322 | 7% | 6% | 3392 |
| 8 | SOMATIC HYPERMUTATION | authKW | 118865 | 1% | 63% | 286 |
| 9 | ANTIBODY ENGINEERING | authKW | 116806 | 1% | 60% | 293 |
| 10 | FC RECEPTOR | authKW | 94540 | 1% | 39% | 363 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Immunology | 314323 | 39% | 3% | 18501 |
| 2 | Biochemistry & Molecular Biology | 30477 | 24% | 1% | 11455 |
| 3 | Biochemical Research Methods | 20793 | 8% | 1% | 3701 |
| 4 | Medicine, Research & Experimental | 10877 | 7% | 1% | 3231 |
| 5 | Cell Biology | 8925 | 9% | 1% | 4253 |
| 6 | Biotechnology & Applied Microbiology | 5218 | 6% | 1% | 2806 |
| 7 | Pharmacology & Pharmacy | 2409 | 7% | 0% | 3254 |
| 8 | Biophysics | 1890 | 3% | 0% | 1615 |
| 9 | Rheumatology | 1746 | 1% | 1% | 670 |
| 10 | Oncology | 1736 | 5% | 0% | 2564 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | PROT ANALYT CHEM | 43410 | 0% | 73% | 90 |
| 2 | IMMUNOL | 34348 | 5% | 3% | 2166 |
| 3 | LATE STAGE PHARMACEUT DEV | 29182 | 0% | 83% | 53 |
| 4 | CONCEPTUAL IMMUNOL GRP | 22207 | 0% | 90% | 37 |
| 5 | IMMUNOL GENOM MED | 20049 | 0% | 57% | 53 |
| 6 | ANALYT FORMULAT SCI | 18651 | 0% | 70% | 40 |
| 7 | MOL GENET IMMUNOL | 17714 | 0% | 41% | 65 |
| 8 | PROC PROD DEV | 15911 | 0% | 44% | 55 |
| 9 | EARLY STAGE PHARMACEUT DEV | 15371 | 0% | 64% | 36 |
| 10 | FORMULAT SCI | 13574 | 0% | 41% | 50 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | MABS | 150242 | 1% | 53% | 424 |
| 2 | MOLECULAR IMMUNOLOGY | 145333 | 3% | 18% | 1257 |
| 3 | JOURNAL OF IMMUNOLOGY | 138322 | 7% | 6% | 3392 |
| 4 | EUROPEAN JOURNAL OF IMMUNOLOGY | 80517 | 3% | 10% | 1279 |
| 5 | JOURNAL OF IMMUNOLOGICAL METHODS | 65753 | 2% | 10% | 990 |
| 6 | JOURNAL OF EXPERIMENTAL MEDICINE | 58439 | 2% | 9% | 1057 |
| 7 | INTERNATIONAL IMMUNOLOGY | 30777 | 1% | 11% | 437 |
| 8 | HYBRIDOMA | 24911 | 1% | 13% | 283 |
| 9 | BIOANALYSIS | 22895 | 0% | 15% | 226 |
| 10 | IMMUNOLOGY | 20416 | 1% | 6% | 532 |
Author Key Words |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | PHAGE DISPLAY | 301510 | 2% | 41% | 1118 | Search PHAGE+DISPLAY | Search PHAGE+DISPLAY |
| 2 | BIOSIMILAR | 156226 | 1% | 64% | 370 | Search BIOSIMILAR | Search BIOSIMILAR |
| 3 | CATALYTIC ANTIBODIES | 152142 | 1% | 79% | 291 | Search CATALYTIC+ANTIBODIES | Search CATALYTIC+ANTIBODIES |
| 4 | SOMATIC HYPERMUTATION | 118865 | 1% | 63% | 286 | Search SOMATIC+HYPERMUTATION | Search SOMATIC+HYPERMUTATION |
| 5 | ANTIBODY ENGINEERING | 116806 | 1% | 60% | 293 | Search ANTIBODY+ENGINEERING | Search ANTIBODY+ENGINEERING |
| 6 | FC RECEPTOR | 94540 | 1% | 39% | 363 | Search FC+RECEPTOR | Search FC+RECEPTOR |
| 7 | BISPECIFIC ANTIBODY | 88268 | 0% | 62% | 216 | Search BISPECIFIC+ANTIBODY | Search BISPECIFIC+ANTIBODY |
| 8 | FCRN | 86848 | 0% | 88% | 149 | Search FCRN | Search FCRN |
| 9 | ANTIBODY DRUG CONJUGATE | 85186 | 0% | 57% | 224 | Search ANTIBODY+DRUG+CONJUGATE | Search ANTIBODY+DRUG+CONJUGATE |
| 10 | AFFINITY MATURATION | 84819 | 0% | 64% | 198 | Search AFFINITY+MATURATION | Search AFFINITY+MATURATION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 3 |